Skip to main content
. 2012 Jul 24;6(7):e1726. doi: 10.1371/journal.pntd.0001726

Figure 2. Cumulative prevalence according to the sampling effort.

Figure 2

Cumulative infection prevalences for (a) S. mekongi and (b) O. viverrini by the number over consecutive days of stool specimen collection (x-axis). Each point on a curve represents a cumulative prevalence value for each sampling effort (number of Kato-Katz thick smears per stool specimen). At baseline (day 0), n = 90; after treatment (days 28–30), n = 66.